Natural health product · NPN 80128362
SIBU
Yes: licensed in Canada
The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.
Licence status Active; licensed December 1, 2023.
- Natural Product Number (NPN)
- 80128362
- Licence holder
- Sibu, Llc
- Dosage form
- Capsule, soft
- Route
- Oral
- Licensing route
- General (non-traditional)
- First licensed
- December 1, 2023
Also sold as
Other product names on the same licence.
- EVOMEGA7
- Femininity
- Femininity & Sea Berry Therapy
- SIBU Femininity
- Sea Berry Therapy
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| Vitamin D | 1,000 IU | Cholecalciferol |
| Vitamin D | 25 microgram | Cholecalciferol |
| Hippophae rhamnoides | 400 mg | hippophae rhamnoides - fruit; 51.5 % Omega-7 fatty acids |
| Schizochytrium spp. | 98 mg | Schizochytrium spp. - Whole; 70 % Docosahexaenoic acid |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- Helps to maintain/support immune function/the immune system. Helps with immune function/the immune system. Source of Omega-7 fatty acids. Helps in the development and maintenance of bones/(and) teeth. Helps to build strong bones/(and) teeth. Vitamin D intake, when combined with sufficient calcium, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis.
Non-medicinal ingredients
Vitamin E; Glycerin; Water; Tapioca Starch, Modified; Medium chain triglycerides